At the ASCO Annual Meeting in June 2011, we presented complete results from our Phase I clinical trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of patients with advanced solid tumors with liver involvement.
Read our press release ALN-VSP PhI ClinicalStudyResults-ASCO2011 (1.2MB PPT) ALN-VSP RNAi Roundtable, May 2011 (2.2 MB PPT) Listen to Dr. Jared Gollob discuss ALN-VSP data at ASCO 2011 (3.1MB MP3)Monthly Archives For: June 2011
June 22, 2011
Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery.
June 18, 2011
Synergistic Silencing: Combinations of Lipid-like Materials for Efficacious siRNA Delivery
June 18, 2011
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter.
June 15, 2011
ALN-HTT HDSA Presentation
In June 2011, our scientists presented an update on our Huntington’s disease program, ALN-HTT, at the 26th Annual HDSA National Convention.
HDSA 2011 Presentation (1.8MB PPT)
June 8, 2011
MicroRNAs 103 and 107 regulate insulin sensitivity.
June 6, 2011
